CiVentiChem

Cary, United States Founded: 1994 • Age: 32 yrs Acquired By Sterling Pharma Solutions
Contract research and manufacturing services are offered for pharmaceuticals.
Annual revenue $9.9M Latest available
Total funding - Funding intelligence
Employees 81 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About CiVentiChem

CiVentiChem is a company based in Cary (United States) founded in 1994 was acquired by Sterling Pharma Solutions in April 2019. The company has 81 employees as of April 04, 2024. CiVentiChem offers products and services including Custom Research Services, Manufacturing Services, and Compound Search. CiVentiChem operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.

  • Headquarter Cary, United States
  • Employees 81 as on 04 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Civentichem (India) Private Limited
  • Date of Incorporation 24 May, 2001
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $9.86 M (USD)
    -7.49
    as on Mar 31, 2023
  • Net Profit
    $188.74 K (USD)
    -78.58
    as on Mar 31, 2023
  • EBITDA
    $2.44 M (USD)
    0.39
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    81

    as on Apr 04, 2024

  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CiVentiChem

CiVentiChem offers a comprehensive portfolio of products and services, including Custom Research Services, Manufacturing Services, and Compound Search.

Product name locked
Category locked
Primary

Delivers solutions for complex chemistry problems through specialized research.

Product name locked
Category locked
Locked

Produces chemical compounds and intermediates for various applications.

Product name locked
Category locked
Locked

Enables searching and downloading of chemical compounds for research needs.

People of CiVentiChem

Headcount 50-200
Employee Profiles 6
Employee Profiles
People
Batta Madhavarao
Research Scientist
People
Subhash K.
Manager (a.r&d,qc)

Unlock access to complete

Funding Insights of CiVentiChem

Premium access

Detailed funding history for CiVentiChem

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in CiVentiChem

CiVentiChem has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sterling Pharma Solutions.

All
Institutional
Investor Description Founded Year Domain Location
Contract development, manufacturing, and analytical services for APIs are offered.
Locked Locked Locked
Premium access

Investor details for CiVentiChem

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CiVentiChem

Investments
Premium access

Investment portfolio details for CiVentiChem

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CiVentiChem

Premium access

Detailed financials for CiVentiChem

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Civentichem Comparisons

CiVentiChem Primary company
Description
Contract research and manufacturing services are offered for...
Location
Cary, United States
Founded Year
1994
Annual Revenue
$9.86 M (USD)
Net Profit
$188.74 K (USD)
EBITDA
$2.44 M (USD)
Employees
81
As of 2024
Premium access

Peer comparison for CiVentiChem

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CiVentiChem

CiVentiChem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical and biotechnology company
Locked Locked Locked
Contract development, manufacturing, and analytical services for APIs are offered.
Locked Locked Locked
APIs and drug products are developed and valorized in pharmaceuticals.
Locked Locked Locked
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
Locked Locked Locked
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
Locked Locked Locked
APIs are manufactured and custom synthesis services are provided.
Premium access

Detailed competitors of CiVentiChem

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Civentichem

Premium access

Complete news archive for CiVentiChem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CiVentiChem

CiVentiChem was founded in 1994.

CiVentiChem is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.

As of Apr 04, 2024, the latest employee count at CiVentiChem is 81.

Annual revenue of CiVentiChem is $9.86M as on Mar 31, 2023.

Founded in 1994 and based in Cary, United States, CiVentiChem operates as a contract development and manufacturing organization in the pharmaceutical sector. Services provided include API and intermediates manufacturing, process development, analytical support, and medicinal chemistry. A portfolio of 13 API products and approximately 2500 compounds is maintained, supporting various research and production needs.

CiVentiChem's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.

CiVentiChem offers Custom Research Services, Manufacturing Services, and Compound Search.

CiVentiChem has 1 investor. Key investors include Sterling Pharma Solutions.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available